Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
about
A comprehensive overview of radioguided surgery using gamma detection probe technologyInherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesGuidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumoursApplication and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine TumorsClinical applications of Gallium-68PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literatureThe clinical features, diagnosis and management of recurrent thymomaSynthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseasesCurrent knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumoursImaging of gastroenteropancreatic neuroendocrine tumorsHigh management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumoursGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsOptical and relaxometric properties of monometallic (Eu(III), Tb(III), Gd(III)) and heterobimetallic (Re(I)/Gd(III)) systems based on a functionalized bipyridine-containing acyclic ligand.Somatostatin receptor scintigraphy useful in stage I-II Hodgkin's disease: more extended disease identified.Molecular imaging and the unification of multilevel mechanisms and data in medical physics.Improved quality of life in patients treated with Peptide radionuclides.Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling.Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Tumour targeting of Auger emitters using DNA ligands conjugated to octreotate.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer.Endocrine tumours of the pancreas: review and recent advances.Mechanism of acid hypersecretion post curative gastrinoma resectionImaging appearances of metastases from neuroendocrine tumours of the pancreas.Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.Octreotide scintigraphy for the detection of paragangliomas.Multimodal management of neuroendocrine liver metastases.Metastatic insulinoma in a patient with type 2 diabetes mellitus: case report and review of the literatureDetection of insulinoma using (68)Gallium-DOTATATE PET/CT: a case report.Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas.Nuclear medicine applications in the clinical setting. Imaging studies aid disease staging and management.Bombesin receptor-mediated imaging and cytotoxicity: review and current statusScintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogueRhodamine-marked bombesin: a novel means for prostate cancer fluorescence imaging.Molecular imaging of gene expression and protein function in vivo with PET and SPECT.Nuclear medicine applications in molecular imaging.
P2860
Q21245578-5AA3137C-8EFE-4C0E-9E05-867AE0D76CDFQ24647838-61A73EA6-2C18-4FAF-B9E0-A374B8B2BBE3Q24685837-B82FE081-048A-4FE2-B099-37DBD2DEC4BAQ26783272-6EB4FFCE-A774-4A4D-95D5-A309FAD6FEE7Q26849276-CE9C58B2-BF24-43C5-B371-4EFFB0407DBEQ26992201-A3813FC7-AC06-4367-BB24-7BBA8E165145Q27022404-4CFE030F-16D0-4848-8889-11BFF46E0EE0Q27025187-CC10C4BE-3D6B-41A8-8FE7-B95F1CB70C13Q28071483-67AAFF13-601E-4981-BC4D-435C3ACE59E7Q28238305-F7794E12-83A0-4259-A80E-A94AEA91BD7EQ28260008-BC5A7363-D3CE-4A21-9745-DFADFB7A8907Q28290833-E297D149-CD64-4C36-BC50-344EA9BD451BQ31083784-729D2F68-D2D6-40E6-8125-28A980BC8CCAQ33181886-C09FFDE9-8250-46B1-B66B-F6D9B2A707F4Q33367681-DE0D9A6D-1F33-4E6D-814C-ED3552785F2CQ33398609-BA98BBDC-754B-47AB-8E14-D114D9096A8FQ33438326-73A9C7FA-CD47-4614-8604-EE03223AFC64Q33593443-5C3C74D5-65FC-442F-AF46-4C4FC35A1D40Q33840177-DCFC38CF-2DE0-4B4F-A583-9131F24FA5E2Q33915233-23D4E8C7-A79E-43DF-8D2D-0D9FED670859Q34117185-592BC0AC-3DDB-4868-8E8B-4345D239B132Q34157385-547BDFED-F569-4C51-8D3E-BC1DF4D70F4AQ34174906-74354B98-8317-4160-896A-CFB2EDDCFA3DQ34248466-7F3D688D-5458-4A63-A0E8-F796CDFED8CDQ34277286-532EB017-C377-4D10-9C3E-72C54E8ADA47Q34336643-8D853F23-1B55-4F81-B5CF-3FDCAD3EFE95Q34345074-0124939B-23B9-4267-B925-5603B39F488EQ34439941-33B77C1C-65E4-4611-88DB-E95C42F9C06FQ34477028-1279CF64-A9C5-4242-A684-42792A2BB8F4Q34507456-8BC2E15D-338C-4577-A8CE-B0A77D06200EQ34528199-2E101D99-2FFC-482C-AA5B-88351ECE7BA6Q34572156-BAEEE6F0-7AC4-4B07-8788-4CB1BB34F7C1Q34573596-F1D4C662-1BDF-4449-898E-A7F2A1645A71Q34579936-DA966595-30FD-435E-B461-AD3447103E2DQ34663263-CF9C458B-B94E-4AAD-BF0C-03763D2A73EFQ34684387-2E5125F4-D744-4391-AF5D-1C94D110A807Q34724459-D2F28037-8CE5-4721-8358-8B847BB45460Q34752361-E38FBF7D-3932-48CD-9C69-B03C287B2140Q34918519-87BD2C0A-B33F-4858-A76D-99DF9288DE03Q34918545-353E45D5-F2B2-4D57-8301-D6A73B447131
P2860
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Somatostatin receptor scintigr ...... with more than 1000 patients.
@ast
Somatostatin receptor scintigr ...... with more than 1000 patients.
@en
Somatostatin receptor scintigr ...... with more than 1000 patients.
@nl
type
label
Somatostatin receptor scintigr ...... with more than 1000 patients.
@ast
Somatostatin receptor scintigr ...... with more than 1000 patients.
@en
Somatostatin receptor scintigr ...... with more than 1000 patients.
@nl
prefLabel
Somatostatin receptor scintigr ...... with more than 1000 patients.
@ast
Somatostatin receptor scintigr ...... with more than 1000 patients.
@en
Somatostatin receptor scintigr ...... with more than 1000 patients.
@nl
P2093
P356
P1476
Somatostatin receptor scintigr ...... with more than 1000 patients.
@en
P2093
D J Kwekkeboom
E P Krenning
M van Hagen
P T Postema
W A Breeman
W H Bakker
P2888
P304
P356
10.1007/BF00181765
P577
1993-08-01T00:00:00Z